Lack of RNase L attenuates macrophage functions

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Yi, Xin ^a   Zeng, Chun ^a   Liu, Hongli ^d   Chen, Xiaoli ^e   Zhang, Ping ^f   Yun, Boo Seok ^a   Jin, Ge ^c   Zhou, Aimin ^a,b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Xi'an Eighth Hospital   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

^f INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; RIBONUCLEASE L; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME METABOLISM; ENZYME REGULATION; GENE EXPRESSION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION;

ANIMALS; CELL MOVEMENT; CYCLOOXYGENASE 2; CYTOKINES; ENDOCYTOSIS; ENDORIBONUCLEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84891875889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081269     Document Type: Article

References (45)

1. Tanner AR., Arthur MJ, Wright R (1984) Macrophage activation, chronic inflammation and gastrointestinal disease. Gut 25: 760-783.
2. Araki N, Johnson MT, Swanson JA (1996) A Role for Phosphoinositide 3-Kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 135: 1249-1260.
3. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78: 857-902.
4. Montaner LJ, Silva RP, Sun J, Sutterwala S, Hollinshead M, et al. (1999) Type 1 and Type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. J Immunol 162: 4606-4613.
5. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623.
6. Falcone DJ, Borth W, Khan KM, Hajjar KA (2001) Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97: 777-784.
7. Loberg RD, Ying C, Craig M, Yan L, Snyder LA, et al. (2007) CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 9: 556-562.
8. Opalek JM, Ali NA, Lobb JM, Hunter MG, Marsh CB (2007) Alveolar macrophages lack CCR2 expression and do not migrate to CCL2. J Inflamma 4: 19-29.
9. Gomes RN, Figueiredo RT, Bozza FA, Pacheco P, Amancio RT, et al. (2006) Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production. J Immunol 26: 457-463.
10. Wu J, Cunha FQ, Liew FY, Weiser WY (1993) IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J Immunol 151: 4325-4332.
11. Elliott RL, Blobe GC (2005) Role of transforming growth factor Beta in human cancer. J Clin Oncol 23: 2078-2093.
12. Pixley FJ, Stanley ER (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638.
13. Kim JS, Kim JG, Moon MY (2006) Transforming growth factor-β1 regulates macrophage migration via RhoA. Blood 108: 1821-1829.
14. Tsuyoshi T, Takahisa M, Kosuke A, Yoshihiro U, Hiroyuki H, et al. (2008) Lipopolysaccharide induces macrophage migration via prostaglandin D2 and prostaglandin E2. J. Phar and Experi Therap 326: 493-501.
15. Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, et al. (2002) Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. European J. Clin. Invest 32: 360-371.
16. Liang SL, Quirk D, Zhou A (2006) RNase L: its biological roles and regulation. IUBMB Life 58: 508-514.
17. Zhou A, Hassel BA, Silverman RH (1993). Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72: 753-765.
18. Zhou A, Paranjape JM, Hassel BM, Nie H, Shah S, et al. (1998). Impact of RNase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 18: 953-961.
19. Li XL, Blackford JA, Hassel BA (1998) RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J. Virol 72: 2752-2759.
20. Xiang Y, Wang ZR, Murakami J, Plummer J, Klein EA, et alhttp://cancerres.aacrjournals.org/search?author1= John+D. +Carpten&sortspec=date&submit=Submit (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′- oligoadenylates. Cancer Res 63: 6795-6801.
21. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, et al. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′- oligoadenylate-dependent RNase L. EMBO J 16: 6355-6363.
22. Silverman RH., Zhou A, Auerbach MB, Kish D, Gorbachev A, et al. (2002) Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2′,5′-oligoadenylate-dependent RNase L. Viral Immunol 15: 77-83.
23. Leitner WW, Hwang LN, DeVeer ML, Zhou A, Silverman RH, et al. (2003) Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9: 33-39.
24. Zhou A, Molinaro RJ, Malathi K, Silverman RH (2005) Mapping of the human RNASEL promoter and expression in cancer and normal cells. J Interferon Cytokine Res 25: 595-603.
25. Paulnock DM (2000) Book: Macrophage: A Practical Approach. Chapter 3.5: 81-86.
26. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
27. Li XL, Blackford JA, Judge CS, Liu M, Xiao W, et al. (2000) RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J Biol Chem 275: 8880-8888.
28. Shanmugam N, Gaw GIT, Natarajan R (2004) Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53: 795-802.
29. Siddiqui MA, Malathi K (2012) RNase L Induces Autophagy via c-Jun N-terminal Kinase and Double-stranded RNA-dependent Protein Kinase Signaling Pathways. J Biol Chem 287: 43651-43664.
30. Malathi K, Dong B, Gale MJ, Silverman RH (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-820.
31. Stuart LM, Ezekowitz RA (2005) Phagocytosis: elegant complexity. Immunity 22: 539-550.
32. Underhill DM, Goodridge HS (2012) Information processing during phagocytosis. Nat Rev Immunol 12: 492-502.
33. Sampaio NG, Yu W, Cox D, Wyckoff J, Condeelis J, et al. (2011) Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion. J Cell Sci 124: 2021-2031.
34. Adler AF, Leong KW (2010) Emerging links between surface nanotechnology and endocytosis: impact on nonviral gene delivery. Nano Today 5: 553-569.
35. Upham JP, Pickett D, Irimura T, Anders EM, Reading PC (2010) Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 84: 3730-3737.
36. Tnani M, Aliau S, Bayard B (1998) Localization of a molecular form of interferon-regulated RNase L in the cytoskeleton. J Interferon Cytokine Res 18: 361-368.
37. Choi WT, An J (2011) Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases. Exp Biol Med 236: 637-647.
38. Mittal R., Sukumaran SK, Selvaraj SK, Wooster DG, Babu MM, et al. (2010) Fcγ Receptor I Alpha Chain (CD64) Expression in Macrophages Is Critical for the Onset of Meningitis by Escheichia coli K1. PLos Pathog 6: e1001203. doi:10.1371/journal.ppat.100120.
39. Peiser L, Gough PJ, Kodama T, Gordon S (2000) Macrophage class A scavenger receptor-mediated phagocytosis of escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun 68: 1953-1963.
40. Raveh D, Kruskal BA, Farland J, Ezekowitz RAB (1998) Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J. Leukoc. Biol 64: 108-113.
41. Ezekowitz RAB, Sastry K, Bailly P, Warner A (1990) Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med 172: 1785-1794.
42. Ezekowitz RAB, Williams DJ, Koziel H, Armstrong MYK, Warner A, et al. (1991) Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351: 155-158.
43. Kruskal BA, Super M, Rogers R, Ezekowitz RAB (1994) The macrophage mannose receptor can mediate the uptake of Mycobacterium avium-intracellulare. Pediat. Res 35: 184.
44. Li XL, Ezelle HJ, Kang TJ, Zhang L, Shirey KA, et al. (2008) An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity. Proc Natl Acad Sci U S A 105: 20816-20821.
45. Henry CJ, Huang Y, Wynne AM, Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23: 309-317.